Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans

Psychopharmacology

Volumn 103, Issue 2, 1991, Pages 258-264

  Lee, Myung A ^a   Nash, J Frank ^a   Barnes, Marianne ^a   Meltzer, Herbert Y ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

5 HT1C 5 HT2 receptors; 5 Hydroxytryptophan; Cortisol; Prolactin; Ritanserin

Indexed keywords

5 HYDROXYTRYPTOPHAN; RITANSERIN; SEROTONIN 1C RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG ANTAGONISM; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RADIOIMMUNOASSAY; VOLUNTEER;

5-HYDROXYTRYPTOPHAN; ADULT; CORTICOTROPIN; HUMAN; HYDROCORTISONE; MALE; PIPERIDINES; PROLACTIN; RITANSERIN; SEROTONIN ANTAGONISTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026020188     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02244213     Document Type: Article

References (46)

1. General pharmacological profile of ketanserin (R 41 468), a selective 5-HT2 receptor antagonist
2. Failure of oral 5-hydroxytryptophan administration to affect prolactin secretion in man
3. l-Tryptophan and prolactin release: evidence for interaction between 5-HT1 and 5-HT2 receptors
4. Inhibition of prolactin release by metergoline administration in man
5. Ritanserin, a serotonin-S2 receptor antagonist, does not prevent 5-hydroxytryptophan-induced β-EP, β-LPH and cortisol secretion
6. Prolactin suppression by serotonin antagonists in man; further evidence for serotonergic control of prolactin secretion
7. Influence on the endocrine system
8. l-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain
9. Alterations of central serotonin and dopamine-turnover in rats treated with ipsapirone and other 5-hydroxy-tryptamine1A agonists with potential anxiolytic properties
10. Failure of 5-hydroxytryptophan to stimulate prolactin and growth hormone secretion in man
11. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects
12. Endocrinological function in schizophrenic patients under haloperidol treatment plasma RPL, HGH and 5-HT levels after l-5-HTP loading
13. Functional correlates of serotonin 5-HT1 recognition sites
14. The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to l-tryptophan
15. Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder
16. Effects of m-chlorophenylpiperazine normal subjects: a dose-response study
17. Effects of 5-hydroxytryptophan on plasma prolactin levels in man
18. MK-212 increases rat plasma ACTH concentration by activation of 5-HT1C receptor subtype
19. Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5-HT receptor subtype activation
20. Hormone responses to selective serotonergic receptor stimulation in the rat
21. Effect of l-5-hydroxytryptophan infusion on growth hormone and prolactin secretion in man
22. Endocrine responses to 5-HT1A receptor activation by ipsapirone in humans
23. Receptor-binding properties in vitro and in vivo of ritanserin a very potent and long acting serotonin-S2 antagonist
24. Stimulation of serum cortisol and prolactin secretion in man by MK-212, a centrally active serotonin agonist
25. Stimulation of human prolacin secretion by intravenous infusion of l-tryptophan
26. The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatients
27. Central actions of ipsapirone, a new anxiolytic drug, on serotonergic, noradrenegic and dopaminergic function
28. Transient effect of l-5-hydroxytryptophan on pituitary function in men and women
29. Serotonin and mood: neuroendocrine aspects
30. The effect of buspirone on prolactin and growth hormone secretion in man
31. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro
32. Effect of 5-hydroxytryptophan on serum cortisol levels in the major affective disorders and normal controls. I. Enhanced response in depression and mania
33. Effect of serotonin precursors and serotonin agonists on plasma hormone levels
34. 5-HT1C receptor is a prominent serotonin receptor subtype in the central nervous system
35. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor-mediated mechanism of action in humans
36. Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rats
37. Rapid radioimmunoassay for corticotropin in unextracted human plasma
38. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site
39. Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors
40. Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain
41. Differential behavior effects of tryptophan and 5-hydroxytryptophan in vervet monkeys: influence of catecholaminergic neurons
42. Prolactin response to R41468, a new specific 5-HT2 antagonist
43. 5-Hydroxytryptamine receptor “families”
44. Mechanisms of 5-hydroxy- l-tryptophan-induced adrenocorticotropin release: a major role central noradrenergic drive
45. An unexpected effect of l-5-hydroxytryptophan-ethylester combined with a peripheral decarboxylase inhibitor on human serum prolactin
46. Effect of the 5-HT2 antagonist ketanserin on the ECT-induced prolactin release